Stay updated with breaking news from Guy Braunstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ad hoc announcement pursuant to Art. 53 LR Idorsia appoints Guy Braunstein to Chief Medical Officer and Alberto Gimona to Head of Global Clinical Development Guy Braunstein, currently Head of Global
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives US FDA approval of QUVIVIQ (daridorexant) 25 and 50 mg for the treatment of adults with insomnia The approval of QUVIVIQ - 25 & 50 mg
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Korean symphony orchestra unveils 2022 program led by new conductor, David Reiland
Ad hoc announcement pursuant to Art. 53 LR Cenerimod 4 mg showed clinically meaningful improvement in the mSLEDAI-2K* primary efficacy endpoint and other measures of efficacy, consistent with the effect